AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Developmental Care on Comfort, Growth, and Oral Feeding Transition in Preterm Infants

RecruitingNAAges 30 Weeks - 34 WeeksAllFenerbahce University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This randomized controlled study aims to evaluate the effects of kangaroo care combined with maternal voice and fetal positioning on the comfort, growth, and transition to full oral feeding in preterm infants aged 30 to 34 weeks gestation. After ethical approval, eligible infants in the neonatal clinic will be randomly assigned to either the intervention group receiving kangaroo care, maternal voice, and fetal positioning, or a control group receiving only fetal positioning in the incubator. The intervention involves daily one-hour kangaroo care sessions with maternal storytelling, followed by positioning in the lateral fetal posture, continuing at least five days per week until infants achieve full oral feeding. Infant comfort will be assessed regularly using the Neonatal Comfort Behavior Scale before feeding, immediately after kangaroo care, and after fetal positioning. Growth paramete

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Infants with a gestational age between 30-34 weeks. 2. The mother's ability to read and write. 3. The infant must be fully enterally fed at the time of enrollment in the study. 4. Infants who are being fed via orogastric tube at the time of enrollment. 5. Infants whose mothers agree to engage in skin-to-skin contact for 1 hour, five sessions per week, with auditory stimulation (storytelling) for 15 minutes will be included in the study. 6. Infants whose mothers cannot participate in the study (due to health issues or other reasons) or refuse kangaroo care will be placed in the control group, where routine service care will be applied. Exclusion Criteria: 1. Presence of a congenital anomaly or genetic disease. 2. Requirement of ventilator support. 3. Infants receiving antibiotics for sepsis or suspected sepsis. 4. Administration of sedative treatment. 5. Having an intracranial hemorrhage greater than grade II. 6. The mother having a physical condition that prevents skin-to-skin contact. 7. The mother using substances or alcohol.
๐Ÿ’Š

What it tests

  • Kangaroo Care + Maternal Voice + Fetal Position Group
  • control group
๐Ÿ“

Where

1 site
Fenerbahce University
Istanbul, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy